Staicu Mary L, Jeffres Meghan N, Jones Bruce M, Stover Kayla R, Wagner Jamie L, Bland Christopher M
Department of Pharmacy, Rochester General Hospital, Rochester, NY, USA.
Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA.
JAC Antimicrob Resist. 2023 Mar 20;5(2):dlad014. doi: 10.1093/jacamr/dlad014. eCollection 2023 Apr.
The clinical and financial consequences associated with a penicillin-allergy label are increasingly evident and have garnered support from international organizations to prioritize penicillin-allergy delabelling programmes. Most settings lack access to resources including drug allergy specialists and rely on general practitioners (GPs) and pharmacists.
The aim of this scoping review was to identify and describe freely available penicillin-allergy delabelling materials to guide clinicians practising in resource-limited settings with initiative application.
This scoping review searched two grey literature databases, six targeted websites and consulted content experts to identify freely available materials in the English language that provided evidence-based and actionable penicillin-allergy delabelling strategies. Study investigators ranked and voted on which screened resources should be included in the final review. Characteristics of resources were evaluated and compared.
Out of 1191 total citations, 6 open-access resources were included. Penicillin-allergy toolkits featuring various delabelling strategies were identified in four resources. The toolkits supported a broad range of downloadable and adaptable materials, predominantly targeted towards GPs. Patient educational materials were also provided. Another resource highlighted a point-of-care penicillin-allergy risk assessment calculator via a free mobile app that quickly and accurately identified low-risk penicillin-allergic patients. The final resource, a supplemental instructional video, presented impactful and standardized delabelling strategies that clinicians can adopt into daily practices.
Limited penicillin-allergy delabelling materials are available in the grey literature but existing resources provide broad and diverse opportunities. Additional support from health protection agencies is critical to augment ongoing delabelling efforts.
青霉素过敏标签所带来的临床和经济后果日益明显,并得到了国际组织的支持,这些组织将青霉素过敏标签去除计划列为优先事项。大多数医疗机构缺乏包括药物过敏专科医生在内的资源,主要依赖全科医生(GP)和药剂师。
本范围综述的目的是识别和描述免费提供的青霉素过敏标签去除材料,以指导在资源有限环境中主动开展实践的临床医生。
本范围综述检索了两个灰色文献数据库、六个目标网站,并咨询了内容专家,以识别以英语提供的、基于证据且可操作的青霉素过敏标签去除策略的免费材料。研究调查人员对哪些筛选出的资源应纳入最终综述进行了排名和投票。对资源的特征进行了评估和比较。
在总共1191条引文中,纳入了6个开放获取资源。在四个资源中识别出了具有各种标签去除策略的青霉素过敏工具包。这些工具包支持广泛的可下载和可改编材料,主要针对全科医生。还提供了患者教育材料。另一个资源通过一款免费移动应用突出了即时青霉素过敏风险评估计算器,该应用能快速准确地识别低风险青霉素过敏患者。最后一个资源是一个补充教学视频,展示了临床医生可纳入日常实践的有效且标准化的标签去除策略。
灰色文献中可用的青霉素过敏标签去除材料有限,但现有资源提供了广泛多样的机会。卫生防护机构的额外支持对于加强正在进行的标签去除工作至关重要。